Related Experiment Video

Updated: Jun 3, 2026

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

Concept and Management of Treatment Resistant Schizophrenia (TRS)

Nitesh Painuly1, Nitin Gupta, Ajit Avasthi

  • 1Senior Resident, Dept. of Psychiatry, PGIMER, Chandigarh - 160 012, India. medinst@pgi.chd.nic.in.

Indian Journal of Psychiatry
|March 17, 2011
PubMed

Insights

Treatment-resistant schizophrenia (TRS) affects many patients, with clozapine being the primary treatment. Further research into biological factors and management strategies for TRS is crucial for improved patient outcomes.

Area of Science:

  • Psychiatry
  • Neuroscience
  • Pharmacology

Background:

  • Treatment resistance is a significant challenge in schizophrenia management globally.
  • The definition and understanding of Treatment-Resistant Schizophrenia (TRS) require further refinement.
  • Biological factors are implicated in the development of TRS.

Purpose of the Study:

  • To review the current understanding and management of Treatment-Resistant Schizophrenia (TRS).
  • To highlight the role of pharmacological and non-pharmacological interventions in TRS.
  • To emphasize the need for continued research in TRS.

Main Methods:

  • Literature review of existing studies on Treatment-Resistant Schizophrenia.
  • Analysis of current treatment guidelines and evidence for pharmacological agents.
  • Examination of the role of psychosocial interventions in TRS management.

Main Results:

  • Clozapine remains the gold standard treatment for TRS.
  • Second-generation antipsychotics are recommended, but efficacy varies.
  • Evidence is growing for the utility of other medications and electroconvulsive therapy (ECT).
  • Psychosocial interventions are essential components of comprehensive TRS care.

Conclusions:

  • Despite advances, TRS remains a complex condition requiring further investigation.
  • Integrated management approaches combining pharmacotherapy and psychosocial interventions are vital.
  • Future research should focus on elucidating biological underpinnings and optimizing treatment strategies for TRS.
Keywords:
Schizophreniaa typical antipsychoticsclozapinedifficult to treat schizophreniatreatment resistant

More Related Videos

Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder11:17

Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder

Published on: November 25, 2025

Related Concept Videos

Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Strategies for Psychological Disorders01:24

Treatment Strategies for Psychological Disorders

Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...